43 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 43 of 43 clinical reviews.
A clinical head-to-head comparison of tadalafil (Cialis) and alprostadil (Caverject/MUSE) for erectile dysfunction across special populations including post-prostatectomy, diabetes, cardiovascular disease, and spinal cord injury. Evidence-based guidance on switching and selection, with clear boundaries on what is established versus unverified.
A comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn) across special populations including diabetes, post-prostatectomy, cardiovascular disease, older adults, and renal/hepatic impairment. Backed by trial data and real-world evidence.
A detailed comparison of Cialis (tadalafil) and vardenafil (Levitra/Staxyn) covering pricing, insurance coverage, generic availability, clinical efficacy, and access pathways for erectile dysfunction treatment.
A clinical comparison of Cialis (tadalafil) and alprostadil (Caverject/MUSE) covering pricing, insurance coverage, pharmacy access, efficacy data, and practical switching guidance for men with erectile dysfunction.
A detailed clinical comparison of tadalafil (Cialis) versus alprostadil (Caverject/MUSE) for erectile dysfunction, covering long-term durability of response, trial data, switching protocols, and when each option fits.
A detailed comparison of tadalafil (Cialis) and alprostadil (Caverject/MUSE) side effects, including frequency data from key trials, severity grading, and guidance on switching between therapies.
A head-to-head clinical comparison of tadalafil (Cialis) versus generic sildenafil, including the pharmacology behind combining them, the real risks of dual PDE5 inhibitor use, and how to choose between the two.
A comparison of tadalafil (Cialis) vs generic sildenafil across dose ranges, onset, duration, side effects, and real-world trial data to help you choose the right PDE5 inhibitor.
A head-to-head clinical comparison of tadalafil (Cialis) and generic sildenafil for long-term erectile function durability, covering trial data, dosing strategies, switching protocols, and real-world outcomes.
A deep clinical comparison of tadalafil (Cialis) vs generic sildenafil for erectile dysfunction, drawing on head-to-head trials, pharmacokinetics, safety data, and real-world evidence to help you and your doctor choose the right option.
A clinical comparison of tadalafil (Cialis) and generic sildenafil side effects, covering frequency, severity, duration, and which PDE5 inhibitor may be better tolerated for your situation.
Cialis (brand tadalafil) and generic tadalafil contain the same molecule at identical doses. This HealthRX.com clinical review compares efficacy, onset, duration, dosing, cost, and safety across every approved indication so you can make an informed choice with your prescriber.
A thorough, citation-dense comparison of brand Cialis and generic tadalafil covering pharmacokinetics, clinical trial data, real-world effectiveness, cost, and switching guidance for men with ED or BPH.
A clinical deep-dive comparing brand Cialis to generic tadalafil in special populations including men with diabetes, cardiovascular disease, BPH, renal impairment, and older adults. Dosing, safety, and switching guidance from named trials and guidelines.
A thorough clinical comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn), covering mechanism differences, head-to-head trial data, switching rationale, and the serious risks of combining both PDE5 inhibitors.
A clinical comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn) covering efficacy data, onset, duration, side effects, and which PDE5 inhibitor may work better for different patients.
A head-to-head clinical comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn) for long-term erectile function, covering trial data, durability benchmarks, switching criteria, and dosing guidance prepared by the HealthRX.com Editorial Team.
A clinical comparison of Cialis (tadalafil) and Viagra (sildenafil) covering onset, duration, dosing, side effects, and which PDE5 inhibitor fits your lifestyle best.
A head-to-head clinical comparison of tadalafil (Cialis) and sildenafil (Viagra) for long-term erectile function durability, covering trial data, dosing schedules, safety, and when to switch.
A head-to-head comparison of tadalafil (Cialis) and sildenafil (Viagra) drawing on landmark clinical trials, real-world outcomes data, and current prescribing guidelines to help patients and clinicians choose the right PDE5 inhibitor.
A head-to-head clinical comparison of tadalafil (Cialis) and sildenafil (Viagra) covering dose titration schedules, tolerability profiles, onset times, and how to decide which PDE5 inhibitor fits your lifestyle.
Tadalafil didn't work? Sildenafil underwhelming? This evidence-based guide walks through why PDE5 inhibitors fail, how to optimize the one you're on, and exactly when switching makes clinical sense.
A clinical comparison of sildenafil generic tablets versus alprostadil injection (Caverject) and suppository (MUSE) for erectile dysfunction, including when and how to switch between them.
A detailed clinical comparison of sildenafil generic tablets vs alprostadil injection (Caverject) and suppository (MUSE) for erectile dysfunction, covering titration protocols, side-effect profiles, and which patients do better on each drug.
A clinical comparison of generic sildenafil and generic tadalafil for erectile dysfunction, including pharmacology, head-to-head trial data, patient-selection criteria, and the evidence for and against combining both PDE5 inhibitors.
A clinical comparison of generic sildenafil (20-100 mg) and generic tadalafil (2.5-20 mg) for erectile dysfunction, covering efficacy data, onset, duration, dosing, and which PDE5 inhibitor may work better for different patients.
A clinical comparison of sildenafil and tadalafil side effects, covering headache, flushing, visual changes, myalgia, and cardiovascular risk by dose range and half-life.
A clinical comparison of generic sildenafil and generic tadalafil across special populations including men with diabetes, post-prostatectomy, cardiovascular disease, BPH, and older adults. Evidence-based dosing, safety, and switching guidance.
A clinical comparison of sildenafil (generic) and vardenafil (Levitra/Staxyn) for erectile dysfunction, covering efficacy data, onset, duration, dosing, and how to choose between them.
A detailed cost and access comparison of generic tadalafil and alprostadil (Caverject/MUSE) for erectile dysfunction, including insurance coverage, out-of-pocket pricing, pharmacy availability, and switching considerations.
Evidence-based comparison of tadalafil generic (2.5-20 mg) and vardenafil (Levitra/Staxyn) for erectile dysfunction, covering onset, duration, efficacy rates, and clinical trial data.
A detailed clinical comparison of tadalafil generic vs vardenafil side effects, dosing, drug interactions, and which PDE5 inhibitor fits different patient profiles. prepared by the HealthRX.com Editorial Team.
A clinical comparison of tadalafil generic and vardenafil (Levitra/Staxyn) for erectile dysfunction, including what evidence says about switching when one PDE5 inhibitor stops working.
A clinical comparison of vardenafil and alprostadil side effects, covering frequency, severity, and which adverse reactions matter most when choosing between oral PDE5 inhibition and local prostaglandin therapy for erectile dysfunction.
A clinical comparison of vardenafil and alprostadil for erectile dysfunction, covering cost, insurance coverage, efficacy data, access routes, and when each option makes sense.
A clinical comparison of vardenafil and alprostadil for erectile dysfunction: efficacy data, trial results, mechanism differences, and guidance on which drug fits which patient.
A clinical comparison of Viagra (sildenafil) and alprostadil (Caverject/MUSE) covering cost per dose, insurance coverage, generic availability, pharmacy access, and switching protocols for erectile dysfunction treatment.
A clinical comparison of sildenafil (Viagra) and alprostadil (Caverject/MUSE) for erectile dysfunction, covering efficacy rates, mechanisms, trial data, and switching protocols.
Clinical comparison of sildenafil (Viagra) and alprostadil (Caverject/MUSE) for erectile dysfunction, including when and how to switch between these treatments safely.
A detailed comparison of brand-name Viagra and generic sildenafil covering pricing, insurance coverage, pharmacy access, clinical equivalence, and how to switch between them.
A head-to-head comparison of brand-name Viagra and generic sildenafil for long-term erectile function. Same molecule, same clinical outcomes, major cost difference. Learn what the evidence actually shows.
Viagra and generic sildenafil contain the same active molecule at the same doses. This guide explains bioequivalence, how to switch safely, dosing differences, cost comparisons, and what clinical evidence actually says.
Clinical comparison of sildenafil (Viagra) and vardenafil (Levitra/Staxyn) for erectile dysfunction, including pharmacokinetics, efficacy data, side effects, and practical guidance for switching between PDE5 inhibitors.